EGFR and lung cancer: In addition, the majority (72.7%) of late recurrences occurring more than five years after lung cancer surgery have been reported in EGFR-positive non-small-cell lung cancer (NSCLC) [5], highlighting the long-term recurrence potential of EGFR-mutated tumors.